NYSE:HUM - New York Stock Exchange, Inc. - US4448591028 - Common Stock - Currency: USD
262.24
+2.88 (+1.11%)
The current stock price of HUM is 262.24 USD. In the past month the price decreased by -1.98%. In the past year, price decreased by -19.09%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UNH | UNITEDHEALTH GROUP INC | 14.72 | 374.50B | ||
ELV | ELEVANCE HEALTH INC | 12.26 | 95.22B | ||
CNC | CENTENE CORP | 7.73 | 29.69B | ||
MOH | MOLINA HEALTHCARE INC | 14.22 | 17.89B | ||
HQY | HEALTHEQUITY INC | 27.39 | 7.41B | ||
ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.40B | ||
PGNY | PROGYNY INC | 40.07 | 1.96B | ||
CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.74B | ||
NEUE | NEUEHEALTH INC | N/A | 59.34M |
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 65,680 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
HUMANA INC
500 W Main St
Louisville KENTUCKY 40202 US
CEO: Bruce D. Broussard
Employees: 67600
Company Website: https://www.humana.com/
Investor Relations: https://humana.gcs-web.com/
Phone: 15025801000
The current stock price of HUM is 262.24 USD. The price increased by 1.11% in the last trading session.
The exchange symbol of HUMANA INC is HUM and it is listed on the New York Stock Exchange, Inc. exchange.
HUM stock is listed on the New York Stock Exchange, Inc. exchange.
31 analysts have analysed HUM and the average price target is 309.8 USD. This implies a price increase of 18.14% is expected in the next year compared to the current price of 262.24. Check the HUMANA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HUMANA INC (HUM) has a market capitalization of 31.65B USD. This makes HUM a Large Cap stock.
HUMANA INC (HUM) currently has 67600 employees.
HUMANA INC (HUM) has a support level at 256.79 and a resistance level at 265.41. Check the full technical report for a detailed analysis of HUM support and resistance levels.
The Revenue of HUMANA INC (HUM) is expected to grow by 7.85% in the next year. Check the estimates tab for more information on the HUM EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HUMANA INC (HUM) has a dividend yield of 1.32%. The yearly dividend amount is currently 3.55. Check the full fundamental report for a detailed analysis of HUM dividend history, reliability and sustainability.
HUMANA INC (HUM) will report earnings on 2025-04-30, before the market open.
The PE ratio for HUMANA INC (HUM) is 16.2. This is based on the reported non-GAAP earnings per share of 16.19 and the current share price of 262.24 USD. Check the full fundamental report for a full analysis of the valuation metrics for HUM.
The outstanding short interest for HUMANA INC (HUM) is 2.59% of its float. Check the ownership tab for more information on the HUM short interest.
ChartMill assigns a technical rating of 1 / 10 to HUM. When comparing the yearly performance of all stocks, HUM is a bad performer in the overall market: 73.34% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to HUM. While HUM is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months HUM reported a non-GAAP Earnings per Share(EPS) of 16.19. The EPS decreased by -37.71% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.02% | ||
ROA | 2.6% | ||
ROE | 7.37% | ||
Debt/Equity | 0.68 |
ChartMill assigns a Buy % Consensus number of 68% to HUM. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 2.12% and a revenue growth 7.85% for HUM